These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 3045017)

  • 41. Behavior of beta 2-microglobulin (B2-m) serum levels in uremic patients.
    Mioli VA; Balestra E; Bibiano L; Dellabella S; Fanciulli E; Gaffi G; Perilli A; Petroselli F; Ricciatti AM; Carletti P
    Int J Artif Organs; 1994 Nov; 17(11):576-80. PubMed ID: 7744516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dialysis arthropathy, amyloidosis and beta-2 microglobulin.
    Cameron JS
    Pediatr Nephrol; 1987 Apr; 1(2):224-9. PubMed ID: 3153281
    [No Abstract]   [Full Text] [Related]  

  • 43. Combined Waldenström's macroglobulinaemia associated AL and beta-2-microglobulin amyloidosis.
    Jones CH; Kanagasundaram NS; Coral AP; Coyne JD; Will EJ
    Nephrol Dial Transplant; 1997 Dec; 12(12):2708-12. PubMed ID: 9430877
    [No Abstract]   [Full Text] [Related]  

  • 44. [Morphology and diagnosis of hemodialysis--related amyloidosis].
    Ohashi K; Kawai R; Hara M
    Nihon Rinsho; 1992 Jan; 50 Suppl():801-6. PubMed ID: 1578770
    [No Abstract]   [Full Text] [Related]  

  • 45. [Diagnosis and therapy for beta2-microglobulin amyloidosis in the K/DOQI guideline].
    Higuchi N; Maruyama H
    Clin Calcium; 2004 May; 14(5):744-9. PubMed ID: 15577036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eluate from beta 2MG adsorbent beads enhances the expression of IL-1 beta from human monocyte.
    Inoue H; Saito I; Nakazawa R; Azuma N; Suzuki M; Miyasaka N
    Nephrol Dial Transplant; 1995 Nov; 10(11):2161-2. PubMed ID: 8643197
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical and pathogenic factors in dialysis-related amyloidosis: current research findings.
    Gejyo F
    Osteoporos Int; 1997; 7 Suppl 3():S197-201. PubMed ID: 9536332
    [No Abstract]   [Full Text] [Related]  

  • 48. Beta-2-microglobulin levels of dialysis patients with renal amyloidosis secondary to familial Mediterranean fever.
    Sungur C; Ozen S; Ozkuyumcu C; Akpolat T; Yasavul U; Turgan C; Caglar S
    Nephron; 1994; 68(1):152. PubMed ID: 7991035
    [No Abstract]   [Full Text] [Related]  

  • 49. Dialysis arthropathy: outcome after renal transplantation.
    Bardin T; Lebail-Darné JL; Zingraff J; Laredo JD; Voisin MC; Kreis H; Kuntz D
    Am J Med; 1995 Sep; 99(3):243-8. PubMed ID: 7653483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Beta 2-microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis.
    Jadoul M; Noel H; van Ypersele de Strihou C
    Am J Kidney Dis; 1990 Jan; 15(1):86-8. PubMed ID: 2403753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amyloidosis and dialysis: pathophysiological aspects.
    Drüeke TB; Zingraff J; Noël LH; Bardin T; Kuntz D
    Contrib Nephrol; 1988; 62():60-6. PubMed ID: 3282799
    [No Abstract]   [Full Text] [Related]  

  • 52. Beta 2-microglobulin modified with the AGE products of the Maillard reaction in dialysis-related amyloidosis.
    Miyata T; Wada Y; Maeda K
    Contrib Nephrol; 1995; 112():52-64. PubMed ID: 7554993
    [No Abstract]   [Full Text] [Related]  

  • 53. Pseudotumoral amyloidosis of beta 2-microglobulin origin in the buttock of a patient receiving long term haemodialysis.
    Fernández-Alonso J; Rios-Camacho C; Valenzuela-Castaño A; Rocha-Castilla JL
    J Clin Pathol; 1993 Aug; 46(8):771-2. PubMed ID: 8408708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beta-2-microglobulin amyloidosis and osteo-articular pathology of the uremic patient on regular dialysis.
    Brancaccio D; Anelli A; Gallieni M; Padovese P; Coggi G; Uslenghi C
    Contrib Nephrol; 1990; 77():177-86. PubMed ID: 2188786
    [No Abstract]   [Full Text] [Related]  

  • 55. Beta-2-microglobulin-related amyloidosis in long-term hemodialysis patients: possible pathogenetic mechanisms.
    Drüeke T; Zingraff J
    Contrib Nephrol; 1987; 59():99-109. PubMed ID: 3327651
    [No Abstract]   [Full Text] [Related]  

  • 56. Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis.
    Miyata T; Sprague SM
    Nephrol Dial Transplant; 1996; 11 Suppl 3():86-90. PubMed ID: 8840320
    [No Abstract]   [Full Text] [Related]  

  • 57. [Amyloid fibril formation of beta 2-microglobulin].
    Goto Y; Hoshino M
    Tanpakushitsu Kakusan Koso; 2002 May; 47(6):663-9. PubMed ID: 11995332
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical aspects of dialysis-related amyloidosis.
    Schäffer J; Floege J; Koch KM
    Contrib Nephrol; 1995; 112():90-6. PubMed ID: 7554997
    [No Abstract]   [Full Text] [Related]  

  • 59. Dialysis amyloidosis with massive popliteal deposition of beta 2-microglobulin amyloid.
    Brancaccio D; Gallieni M; Padovese P; Anelli A; Coggi G; Uslenghi C
    Lancet; 1988 Oct; 2(8614):802. PubMed ID: 2901651
    [No Abstract]   [Full Text] [Related]  

  • 60. Dialysis amyloidosis.
    Lancet; 1991 Aug; 338(8763):349-50. PubMed ID: 1677703
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.